A significant chunk of Smith & Nephew‘s (FTSE:SN; NYSE:SNN) shareholders withheld their endorsement or voted outright against a $2.5 million "golden hello" for new CEO Olivier Bohuon after an advisory board recommended a veto.
About 30% of the British health care giant’s backer’s either voted against the company’s compensation report or abstained from voting, according to The Guardian.
"It is unclear how a golden hello benefits shareholders," proxy advisor Pirc said ahead of Smith & Nephew’s annual meeting, noting that cash bonuses neared 100% for top management even though SNN missed financial targets, according to the newspaper.
Sign up to get our free newsletters delivered straight to your inbox
About 8% of shareholders vetoed the pay plan outright, with another 22% deliberately abstaining, according to The Guardian.
Smith & Nephew posted profits of $279 million, or 16 cents per share, on sales of $1.12 billion for the 3 months ended Dec. 31, 2011. That’s a 3.7% addition to the top line, although profits were flat at a 0.4% gain, compared with profits of $278 million, or 21 cents per share, on sales of $1.07 billion during the same period in 2010.
For the full year, profits were $961 million, or 65 cents EPS, on sales of $4.27 billion, down 0.8% and up 7.8%, respectively, compared with profits of $969 million, or 69 cents EPS, on sales of $3.96 billion during 2010.
Smith & Nephew tapped Bohuon a year ago to replace David Illingworth. Last week the company named Baroness Virginia Bottomley of Nettlestone to its board of directors.
PhRMA taps Eli Lilly CEO Lechleiter for chairman
The Pharmaceutical Research & Manufacturers of America named Eli Lilly (NYSE:LLY) chairman, president & CEO John Lechleiter chairman. Read more
Response Biomedical names new CEO
Response Biomedical (TSE:RBM) named Jeffrey Purvin CEO effective May 1, replacing Dr. Peter Thompson as interim CEO; Thompson will stay on as chairman. Read more
From Medical Design & Outsourcing
- The most innovative medical device of 2020Abbott (NYSE:ABT) announced today that it received the 2020 Prix Galien USA Award for Best Medical Technology for its MitraClip system. MitraClip, Abbott Park, Ill.-based Abbott’s minimally invasive transcatheter mitral valve repair (TMVR) system, was chosen from a field of 17 other nominees, according to a news release. MitraClip is delivered to the heart through a… […]
- Medtech employees favor Biden in last stretch of presidential campaign fundraisingFormer Vice President Joe Biden is outraising incumbent President Donald Trump nearly 3-to-1 among medtech employees and their families, according to a Medical Design & Outsourcing analysis of OpenSecrets.org data. Check out our breakdown covering 25 of the largest companies. Medtech companies’ employees and their families have donated more than $1.3 million to Biden, versus… […]
- 6 early medical devices that might make your spine tingleMedical Design & Outsourcing has made an annual effort during “spooky season” to shed light on some early medical devices and innovations and the museums that hold them, but this year is a bit different. Last year, we visited the Earl Bakken Museum’s backroom to get a look at early medical devices. A few years… […]
- Integer reports mixed results in Q3Integer Holdings (NYSE:ITGR) today reported third-quarter earnings that beat the Wall Street consensus forecast on earnings — but not on revenue. The Plano, Texas–based medical device contract manufacturing giant reported profits of $30.3 million, or 92¢ per share, off sales of $236 million for the quarter ended Oct. 2, 2020, for steady bottom-line and a top-line… […]
- Dunlee replacement CT tubes win FDA clearanceDunlee this week announced that its DA200P40+LMB CT replacement tube received FDA clearance. The replacement CT tubes feature CoolGlide technology and is an alternative to liquid metal bearing replacement CT tubes for GE Revolution Evo and Optima 660 CT scanners. Liquid metal bearing in CT tubes doesn’t create friction, which results in less wear, according… […]
- Cadence adds Class 8 cleanroom at Virginia HQContract manufacturer Cadence announced the addition of an ISO Class 8 cleanroom at its headquarters located in Staunton, Va. The new cleanroom will be used for the development and manufacturing of novel medical devices. “We are excited about expanding the capabilities at our Virginia facility,” said Cadence operations VP Chris McHugh in a news release.… […]
- Medidata acquires MC10’s digital biomarker businessMedidata announced that it has acquired the digital biomarker business of MC10 to help integrate data from wearable sensors — including clinical-grade metrics — so customers may make clinical trials virtual. MC10’s offerings will bring novel clinical analytics and biosensor capabilities to Medidata’s existing patient cloud solutions in ePRO (patient-reported outcomes), eCOA (clinical outcome assessments)… […]
- What drugmakers need to know about analytical testing for drug-device combinationsPharmaceutical manufacturers need to understand the compatibility and performance of the primary packaging system with both the drug and its delivery system. Jennifer Riter, West Pharmaceutical As more pharmaceutical manufacturers develop combination products, they identify new and complex interactions among packaging components and delivery systems. Understanding this interplay is critical to developing a successful drug-device… […]
- TE Connectivity beats The Street on lower Q4 salesTE Connectivity (NYSE:TEL) today reported its healthcare sales were down by $16 million for the fourth quarter of its 2020 fiscal year. Schaffhausen, Switzerland-based TE Connectivity reported overall sales of $3.261 billion for the quarter ended Sept. 25, 2020, down 8.7% from the same quarter one year ago. Adjusted to exclude one-time items, earnings per share… […]
- 3M slightly down despite Street-beating Q33M (NYSE:MMM) shares took a slight dip today on third-quarter results that finished ahead of the consensus forecast. The St. Paul, Minn.-based company posted profits of $1.4 billion, or $2.43 per share, on sales of $8.4 billion for the three months ended Sept. 30, 2020, for a -10.7% bottom-line slide on sales growth of 4.5%. Adjusted… […]
- Dynocardia lands spot in Dassault Systèmes startup acceleratorMedtech startup Dynocardia, which is developing a continuous, non-invasive blood pressure (BP) measuring device, announced today that it has been selected for the Dassault Systèmes 3DExperience Lab accelerator program. Participation in the accelerator could help Dynocardia expedite the development of its ViTrack technology, which the company touts as a solution to problems stemming from inaccurate,… […]
Leave a Reply
You must be logged in to post a comment.